Medical specialists from France tagged as investigators in clinical trials studying Pulmonary Emphysema

Total 15 results

amandine BRIAULT, MD
Seen in:
- Grenoble, CHU de Grenoble
Trials:
- NCT06181357 (Principal Investigator)
Conditions:
- COPD
Charlotte VERGNENEGRE, MD
Seen in:
- Bordeaux, CHU de Bordeaux
Trials:
- NCT06181357 (Principal Investigator)
Conditions:
- COPD
Christophe Pison, PU-PH
Seen in:
- Grenoble, Hopital Albert Michallon
Trials:
- NCT02439528 (Principal Investigator)
Conditions:
Frederic WALLYN, MD
Seen in:
- Lille, CHU de Lille
- Lille, Hopital Calmette
Trials:
- NCT04517916 (Principal Investigator)
- NCT06181357 (Principal Investigator)
Conditions:
- Emphysema or COPD;
- COPD
Gabriel Thabut, MD
Seen in:
- Paris, Departement d'épidémiologie, Hôpital Bichat
Trials:
- NCT00700934 (Principal Investigator)
Conditions:
- Emphysema;
- Alpha 1-Antitrypsin Deficiency
Hervé DUTAU, MD
Seen in:
- Marseille, APHM
Trials:
- NCT06181357 (Principal Investigator)
Conditions:
- COPD
Jacques BOUTROS, MD
Seen in:
- Nice, CHU de Nice
Trials:
- NCT06181357 (Principal Investigator)
Conditions:
- COPD
Jean-François Mornex, MD
Seen in:
- Rhone, Bron, Hôpital Cardio-Vasculaire et Pneumologique Louis Pradel
Trials:
- NCT01983241 (Principal Investigator)
Conditions:
- Pulmonary Emphysema in Alpha-1 PI Deficiency
Jean-Michel Vergnon, PU-PH
Seen in:
- Saint-Etienne, Hopital Nord
Trials:
- NCT02439528 (Principal Investigator)
Conditions:
nicolas GUIBERT, MD
Seen in:
- Toulouse, CHU Toulouse
- Toulouse, CHU de Toulouse
- Toulouse, Hopital Larrey
Trials:
- NCT04517916 (Principal Investigator)
- NCT04559464 (Principal Investigator)
- NCT06181357 (Principal Investigator)
Conditions:
- Emphysema or COPD;
- Emphysema;
- COPD;
- Severe Emphysema
Olivier BRUGIERE, MD
Seen in:
- Suresnes, Hôpital FOCH
Trials:
- NCT06181357 (Principal Investigator)
Conditions:
- COPD
Samy LACHKAR, MD
Seen in:
- Rouen, CHU Rouen
- Rouen, CHU de Rouen
- Rouen, Hopital Charles Nicolle
Trials:
- NCT04517916 (Principal Investigator)
- NCT05068973 (Principal Investigator)
- NCT06181357 (Principal Investigator)
Conditions:
- Emphysema or COPD;
- Lung Cancer;
- COPD
thomas egenod, MD
Seen in:
- Limoges, CHU Limoges
- Limoges, CHU de Limoges
- Limoges, Hôpital Dupuytren
Trials:
- NCT04517916 (Principal Investigator)
- NCT04559464 (Principal Investigator)
- NCT06181357 (Principal Investigator)
Conditions:
- Emphysema or COPD;
- Emphysema;
- COPD;
- Severe Emphysema
Vincent COTTIN, PU-PH
Seen in:
- Bron, Hospices Civils de Lyon - Hopital Louis Pradel
Trials:
- NCT02439528 (Principal Investigator)
Conditions:
Yoann AMMAR, MD
Seen in:
- Marseille, Hopital Saint Joseph
Trials:
- NCT06181357 (Principal Investigator)
Conditions:
- COPD

Clinical Trials on Pulmonary Emphysema

Pulmonx Corporation

Recruiting

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema (CONVERT_II)

Emphysema or COPD | Emphysema, Pulmonary

Spain, Germany, Italy, Australia
Beijing Municipal Science & Technology Commission

Unknown

A Clinical Evaluation of Baofeikang Granule in Combined Pulmonary Fibrosis and Emphysema Treatment

Combined Pulmonary Fibrosis and Emphysema

China
Asan Medical Center

Unknown

The Microbiome of Sputum, Urine and Feces in Healthy Persons and Chronic Obstructive Pulmonary Disease (COPD) Patients (COPD)

Pulmonary Disease, Chronic Obstructive | Microbiota | Emphysema or COPD

Korea, Republic of
Aarhus University Hospital

Recruiting

The Effect of Treatment of Emphysema With Endobronchial Valves on the Diaphragm Mobility

Chronic Obstructive Pulmonary Disease | Emphysema or COPD

Denmark
Heidelberg University

Unknown

Endoscopic Lung Volume Reduction After Catheter-based CV Measurement in Patients With Heterogeneous Emphysema and Complete Interlobar Fissures

Heterogeneous Emphysema

Germany
Royal Brompton & Harefield NHS Foundation Trust

Completed

Use of Endobronchial Valves in Non-Upper Lobe Heterogeneous Emphysema

Heterogeneous Emphysema

United Kingdom
Aeris Therapeutics

Completed

Biologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous Study

Homogeneous Emphysema

United States
Pulmonx Corporation

Completed

Safety and Feasibility Study of the Chartis System With Heterogeneous Emphysema Prior to Endobronchial Lung Volume Reduction (ELVR)

Heterogeneous Emphysema

Germany
IHF GmbH - Institut für Herzinfarktforschung

Not yet recruiting

BENTO - Bronchoscopic Lung Volume Reduction in Severe Emphysema Using Thermoablation

Emphysema or Chronic Obstructive Pulmonary Disease

Germany
Hospices Civils de Lyon

Unknown

Genetics of the Combined Pulmonary Fibrosis and Emphysema Syndrome (GENES-SEF)

Emphysema | Pulmonary Fibrosis | Healthy Subjects | Combined Pulmonary Fibrosis and Emphysema Syndrome

France

Medical specialists from France tagged as investigators in clinical trials studying Pulmonary Emphysema

Clinical Trials on Pulmonary Emphysema

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations